$IDRA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in IDERA PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in IDERA PHARMACEUTICALS, INC.. Get notifications about new insider transactions in IDERA PHARMACEUTICALS, INC. for free.
Page: < prev 1 2 3 4 5 6 7 8 ... 8 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 09 2014 | IDRA | IDERA PHARMACEUTIC ... | Goldberg Mark Alan | Director | Option Exercise | A | 5.30 | 30,000 | 159,000 | 30,000 | |
Jan 08 2014 | IDRA | IDERA PHARMACEUTIC ... | BRENNER LOUIS MD | Chief Medical Offic ... | Option Exercise | A | 5.04 | 600,000 | 3,024,000 | 600,000 | |
Jan 06 2014 | IDRA | IDERA PHARMACEUTIC ... | GERAGHTY JAMES A | Director | Grant | A | 4.75 | 1,013 | 4,812 | 401,013 | 400 K to 401 K (+0.25 %) |
Jan 06 2014 | IDRA | IDERA PHARMACEUTIC ... | Abdul-Wahab Umari | Director | Grant | A | 4.75 | 1,842 | 8,750 | 65,320 | 63.5 K to 65.3 K (+2.90 %) |
Dec 12 2013 | IDRA | IDERA PHARMACEUTIC ... | Sullivan Timothy M | VP Development Prog ... | Option Exercise | A | 2.56 | 200,000 | 512,000 | 200,000 | |
Dec 12 2013 | IDRA | IDERA PHARMACEUTIC ... | Arbeit Robert D. | VP Clinical Develop ... | Option Exercise | A | 2.56 | 200,000 | 512,000 | 200,000 | |
Dec 12 2013 | IDRA | IDERA PHARMACEUTIC ... | Arcudi III Louis J | Chief Financial Off ... | Option Exercise | A | 2.56 | 300,000 | 768,000 | 300,000 | |
Dec 12 2013 | IDRA | IDERA PHARMACEUTIC ... | AGRAWAL SUDHIR | CEO & President | Option Exercise | A | 2.56 | 850,000 | 2,176,000 | 850,000 | |
Dec 09 2013 | IDRA | IDERA PHARMACEUTIC ... | GERAGHTY JAMES A | Director | Buy | P | 2.72 | 40,000 | 108,800 | 400,000 | 360 K to 400 K (+11.11 %) |
Oct 03 2013 | IDRA | IDERA PHARMACEUTIC ... | Abdul-Wahab Umari | Director | Grant | A | 1.80 | 4,861 | 8,750 | 63,478 | 58.6 K to 63.5 K (+8.29 %) |
Oct 02 2013 | IDRA | IDERA PHARMACEUTIC ... | Abdul-Wahab Umari | Director | Buy | P | 0.00 | 929,032 | 0 | 0 | -929,032 to 0 (-100.00 %) |
Oct 02 2013 | IDRA | IDERA PHARMACEUTIC ... | Abdul-Wahab Umari | Director | Buy | P | 0.00 | 845,161 | 0 | 0 | -845,161 to 0 (-100.00 %) |
Oct 02 2013 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | Director | Buy | P | 0.00 | 929,032 | 0 | 0 | -929,032 to 0 (-100.00 %) |
Oct 02 2013 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | Director | Buy | P | 0.00 | 845,161 | 0 | 0 | -845,161 to 0 (-100.00 %) |
Sep 18 2013 | IDRA | IDERA PHARMACEUTIC ... | KARR ROBERT W | Director | Buy | P | 1.76 | 5,750 | 10,114 | 6,299 | 549 to 6.3 K (+1,047.36 %) |
Sep 17 2013 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Buy | P | 1.82 | 13,561 | 24,643 | 18,794 | 5.2 K to 18.8 K (+259.14 %) |
Sep 16 2013 | IDRA | IDERA PHARMACEUTIC ... | GERAGHTY JAMES A | Director | Buy | P | 1.90 | 60,000 | 114,000 | 360,000 | 300 K to 360 K (+20.00 %) |
Aug 20 2013 | IDRA | IDERA PHARMACEUTIC ... | GERAGHTY JAMES A | Director | Buy | P | 1.75 | 300,000 | 525,000 | 300,000 | 0 to 300 K |
Aug 16 2013 | IDRA | IDERA PHARMACEUTIC ... | Abdul-Wahab Umari | Director | Option Exercise | A | 1.50 | 40,000 | 60,000 | 40,000 | |
Aug 16 2013 | IDRA | IDERA PHARMACEUTIC ... | Slater Eve Elizabeth | Director | Option Exercise | A | 1.50 | 40,000 | 60,000 | 40,000 | |
Aug 16 2013 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Option Exercise | A | 1.50 | 40,000 | 60,000 | 40,000 | |
Aug 16 2013 | IDRA | IDERA PHARMACEUTIC ... | MacCoss Malcolm | Director | Option Exercise | A | 1.50 | 40,000 | 60,000 | 40,000 | |
Aug 16 2013 | IDRA | IDERA PHARMACEUTIC ... | KARR ROBERT W | Director | Option Exercise | A | 1.50 | 40,000 | 60,000 | 40,000 | |
Aug 16 2013 | IDRA | IDERA PHARMACEUTIC ... | HARTLEY C KEITH | Director | Option Exercise | A | 1.50 | 40,000 | 60,000 | 40,000 | |
Aug 16 2013 | IDRA | IDERA PHARMACEUTIC ... | ZEIN YOUSSEF EL | Director | Option Exercise | A | 1.50 | 40,000 | 60,000 | 40,000 | |
Aug 16 2013 | IDRA | IDERA PHARMACEUTIC ... | GERAGHTY JAMES A | Director | Option Exercise | A | 1.50 | 40,000 | 60,000 | 40,000 | |
Aug 16 2013 | IDRA | IDERA PHARMACEUTIC ... | AGRAWAL SUDHIR | CEO & President | Option Exercise | A | 1.50 | 500,000 | 750,000 | 500,000 | |
Jul 30 2013 | IDRA | IDERA PHARMACEUTIC ... | Abdul-Wahab Umari | Director | Option Exercise | A | 1.00 | 20,000 | 20,000 | 20,000 | |
Jul 30 2013 | IDRA | IDERA PHARMACEUTIC ... | Slater Eve Elizabeth | Director | Option Exercise | A | 1.00 | 20,000 | 20,000 | 20,000 | |
Jul 30 2013 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Option Exercise | A | 1.00 | 20,000 | 20,000 | 20,000 | |
Jul 30 2013 | IDRA | IDERA PHARMACEUTIC ... | MacCoss Malcolm | Director | Option Exercise | A | 1.00 | 20,000 | 20,000 | 20,000 | |
Jul 30 2013 | IDRA | IDERA PHARMACEUTIC ... | KARR ROBERT W | Director | Option Exercise | A | 1.00 | 20,000 | 20,000 | 20,000 | |
Jul 30 2013 | IDRA | IDERA PHARMACEUTIC ... | HARTLEY C KEITH | Director | Option Exercise | A | 1.00 | 20,000 | 20,000 | 20,000 | |
Jul 10 2013 | IDRA | IDERA PHARMACEUTIC ... | GERAGHTY JAMES A | Director | Option Exercise | A | 0.71 | 450,000 | 319,500 | 450,000 | |
Jul 30 2013 | IDRA | IDERA PHARMACEUTIC ... | ZEIN YOUSSEF EL | Director | Option Exercise | A | 1.00 | 20,000 | 20,000 | 20,000 | |
Jul 03 2013 | IDRA | IDERA PHARMACEUTIC ... | Abdul-Wahab Umari | Director | Grant | A | 0.70 | 12,500 | 8,750 | 58,617 | 46.1 K to 58.6 K (+27.10 %) |
May 24 2013 | IDRA | IDERA PHARMACEUTIC ... | Arcudi III Louis J | Chief Financial Off ... | Option Exercise | A | 0.69 | 348,333 | 240,350 | 348,333 | |
May 24 2013 | IDRA | IDERA PHARMACEUTIC ... | Sullivan Timothy M | VP Development Prog ... | Option Exercise | A | 0.69 | 217,750 | 150,248 | 217,750 | |
May 24 2013 | IDRA | IDERA PHARMACEUTIC ... | Arbeit Robert D. | VP Clinical Develop ... | Option Exercise | A | 0.69 | 217,750 | 150,248 | 217,750 | |
May 17 2013 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | Director | Option Exercise | P | 0.47 | 2,400,000 | 1,128,000 | 0 | |
May 17 2013 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | Director | Option Exercise | P | 0.47 | 2,600,000 | 1,222,000 | 0 | |
May 17 2013 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | Director | Option Exercise | A | 0.79 | 110,901 | 87,612 | 0 | |
May 17 2013 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | Director | Option Exercise | A | 0.79 | 313,341 | 247,539 | 0 | |
May 17 2013 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | Director | Option Exercise | A | 0.79 | 575,758 | 454,849 | 0 | |
May 17 2013 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | Director | Option Exercise | A | 0.61 | 1,000,000 | 610,000 | 0 | |
May 17 2013 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | Director | Buy | P | 0.00 | 2,400,000 | 0 | 0 | -2,400,000 to 0 (-100.00 %) |
May 17 2013 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | Director | Buy | P | 0.00 | 2,600,000 | 0 | 0 | -2,600,000 to 0 (-100.00 %) |
May 24 2013 | IDRA | IDERA PHARMACEUTIC ... | AGRAWAL SUDHIR | Chairman, CEO & Pre ... | Option Exercise | A | 0.69 | 500,000 | 345,000 | 500,000 | |
May 17 2013 | IDRA | IDERA PHARMACEUTIC ... | Abdul-Wahab Umari | Director | Option Exercise | P | 0.47 | 2,400,000 | 1,128,000 | 0 | |
May 17 2013 | IDRA | IDERA PHARMACEUTIC ... | Abdul-Wahab Umari | Director | Option Exercise | P | 0.47 | 2,600,000 | 1,222,000 | 0 | |
May 17 2013 | IDRA | IDERA PHARMACEUTIC ... | Abdul-Wahab Umari | Director | Option Exercise | A | 0.79 | 110,901 | 87,612 | 0 | |
May 17 2013 | IDRA | IDERA PHARMACEUTIC ... | Abdul-Wahab Umari | Director | Option Exercise | A | 0.79 | 313,341 | 247,539 | 0 | |
May 17 2013 | IDRA | IDERA PHARMACEUTIC ... | Abdul-Wahab Umari | Director | Option Exercise | A | 0.79 | 575,758 | 454,849 | 0 | |
May 17 2013 | IDRA | IDERA PHARMACEUTIC ... | Abdul-Wahab Umari | Director | Option Exercise | A | 0.61 | 1,000,000 | 610,000 | 0 | |
May 17 2013 | IDRA | IDERA PHARMACEUTIC ... | Abdul-Wahab Umari | Director | Buy | P | 0.00 | 2,400,000 | 0 | 0 | -2,400,000 to 0 (-100.00 %) |
May 17 2013 | IDRA | IDERA PHARMACEUTIC ... | Abdul-Wahab Umari | Director | Buy | P | 0.00 | 2,600,000 | 0 | 0 | -2,600,000 to 0 (-100.00 %) |
May 09 2013 | IDRA | IDERA PHARMACEUTIC ... | HARTLEY C KEITH | Director | Option Exercise | P | 0.47 | 90,000 | 42,300 | 90,000 | |
May 09 2013 | IDRA | IDERA PHARMACEUTIC ... | HARTLEY C KEITH | Director | Buy | P | 0.49 | 90,000 | 44,100 | 92,434 | 2.4 K to 92.4 K (+3,697.62 %) |
Apr 03 2013 | IDRA | IDERA PHARMACEUTIC ... | Abdul-Wahab Umari | Director | Grant | A | 0.47 | 18,617 | 8,750 | 18,617 | 0 to 18.6 K |
Nov 15 2012 | IDRA | IDERA PHARMACEUTIC ... | AGRAWAL SUDHIR | Chairman, CEO & Pre ... | Option Exercise | A | 1.16 | 5,863 | 6,801 | 25,551 | |
Nov 15 2012 | IDRA | IDERA PHARMACEUTIC ... | AGRAWAL SUDHIR | Chairman, CEO & Pre ... | Option Exercise | A | 1.16 | 83,750 | 96,899 | 365,000 | |
Nov 15 2012 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | Director | Option Exercise | A | 0.00 | 424,242 | 0 | 0 | |
Nov 15 2012 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | Director | Option Exercise | A | 0.70 | 8,484,840 | 5,939,388 | 0 | |
Nov 15 2012 | IDRA | IDERA PHARMACEUTIC ... | Arbeit Robert D. | VP Clinical Develop ... | Option Exercise | A | 1.16 | 25,125 | 29,070 | 109,500 | |
Nov 15 2012 | IDRA | IDERA PHARMACEUTIC ... | Arcudi III Louis J | Chief Financial Off ... | Option Exercise | A | 1.16 | 33,500 | 38,760 | 146,000 | |
Nov 15 2012 | IDRA | IDERA PHARMACEUTIC ... | Sullivan Timothy M | VP Development Prog ... | Option Exercise | A | 1.16 | 25,125 | 29,070 | 109,500 | |
Jul 02 2012 | IDRA | IDERA PHARMACEUTIC ... | MacCoss Malcolm | Director | Grant | A | 1.17 | 1,216 | 1,424 | 3,091 | 1.9 K to 3.1 K (+64.85 %) |
Jun 13 2012 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Option Exercise | A | 0.91 | 20,000 | 18,200 | 20,000 | |
Jun 12 2012 | IDRA | IDERA PHARMACEUTIC ... | Slater Eve Elizabeth | Director | Option Exercise | A | 0.91 | 20,000 | 18,200 | 20,000 | |
Jun 12 2012 | IDRA | IDERA PHARMACEUTIC ... | MacCoss Malcolm | Director | Option Exercise | A | 0.91 | 20,000 | 18,200 | 20,000 | |
Jun 12 2012 | IDRA | IDERA PHARMACEUTIC ... | KARR ROBERT W | Director | Option Exercise | A | 0.91 | 20,000 | 18,200 | 20,000 | |
Jun 12 2012 | IDRA | IDERA PHARMACEUTIC ... | HARTLEY C KEITH | Director | Option Exercise | A | 0.91 | 20,000 | 18,200 | 20,000 | |
Jun 12 2012 | IDRA | IDERA PHARMACEUTIC ... | ZEIN YOUSSEF EL | Director | Option Exercise | A | 0.91 | 20,000 | 18,200 | 20,000 | |
Apr 25 2012 | IDRA | IDERA PHARMACEUTIC ... | Senator Investment Group LP | 10% Owner | Sell | S | 1.88 | 91,000 | 171,080 | 2,724,700 | 2.8 M to 2.7 M (-3.23 %) |
Apr 19 2012 | IDRA | IDERA PHARMACEUTIC ... | Senator Investment Group LP | 10% Owner | Sell | S | 2.09 | 42,000 | 87,780 | 2,880,000 | 2.9 M to 2.9 M (-1.44 %) |
Apr 19 2012 | IDRA | IDERA PHARMACEUTIC ... | Senator Investment Group LP | 10% Owner | Sell | S | 2.15 | 74,000 | 159,100 | 2,922,000 | 3 M to 2.9 M (-2.47 %) |
Apr 19 2012 | IDRA | IDERA PHARMACEUTIC ... | Senator Investment Group LP | 10% Owner | Sell | S | 2.15 | 4,000 | 8,600 | 2,996,000 | 3 M to 3 M (-0.13 %) |
Apr 13 2012 | IDRA | IDERA PHARMACEUTIC ... | Senator Investment Group LP | 10% Owner | Sell | S | 1.85 | 26,300 | 48,655 | 3,000,000 | 3 M to 3 M (-0.87 %) |
Apr 11 2012 | IDRA | IDERA PHARMACEUTIC ... | Senator Investment Group LP | 10% Owner | Sell | S | 1.87 | 82,000 | 153,340 | 3,026,300 | 3.1 M to 3 M (-2.64 %) |
Apr 11 2012 | IDRA | IDERA PHARMACEUTIC ... | Senator Investment Group LP | 10% Owner | Sell | S | 1.91 | 15,200 | 29,032 | 3,108,300 | 3.1 M to 3.1 M (-0.49 %) |
Apr 04 2012 | IDRA | IDERA PHARMACEUTIC ... | Senator Investment Group LP | 10% Owner | Sell | S | 1.87 | 50,000 | 93,500 | 3,123,500 | 3.2 M to 3.1 M (-1.58 %) |
Apr 04 2012 | IDRA | IDERA PHARMACEUTIC ... | Senator Investment Group LP | 10% Owner | Sell | S | 1.90 | 11,624 | 22,086 | 3,173,500 | 3.2 M to 3.2 M (-0.36 %) |
Apr 04 2012 | IDRA | IDERA PHARMACEUTIC ... | Senator Investment Group LP | 10% Owner | Sell | S | 1.92 | 49,381 | 94,812 | 3,185,124 | 3.2 M to 3.2 M (-1.53 %) |
Mar 15 2012 | IDRA | IDERA PHARMACEUTIC ... | Sullivan Timothy M | VP Development Prog ... | Option Exercise | A | 1.16 | 9,375 | 10,847 | 84,375 | |
Mar 15 2012 | IDRA | IDERA PHARMACEUTIC ... | Arbeit Robert D. | VP Clinical Develop ... | Option Exercise | A | 1.16 | 9,375 | 10,847 | 84,375 | |
Mar 15 2012 | IDRA | IDERA PHARMACEUTIC ... | Arcudi III Louis J | Chief Financial Off ... | Option Exercise | A | 1.16 | 12,500 | 14,463 | 112,500 | |
Mar 15 2012 | IDRA | IDERA PHARMACEUTIC ... | AGRAWAL SUDHIR | Chairman, CEO & Pre ... | Option Exercise | A | 1.16 | 2,188 | 2,538 | 19,688 | |
Mar 15 2012 | IDRA | IDERA PHARMACEUTIC ... | AGRAWAL SUDHIR | Chairman, CEO & Pre ... | Option Exercise | A | 1.16 | 31,250 | 36,156 | 281,250 | |
Jan 04 2012 | IDRA | IDERA PHARMACEUTIC ... | AGRAWAL SUDHIR | Chairman, CEO & Pre ... | Option Exercise | A | 1.16 | 8,750 | 10,150 | 8,750 | |
Jan 04 2012 | IDRA | IDERA PHARMACEUTIC ... | AGRAWAL SUDHIR | Chairman, CEO & Pre ... | Option Exercise | A | 1.16 | 8,750 | 10,150 | 8,750 | |
Dec 07 2011 | IDRA | IDERA PHARMACEUTIC ... | Sullivan Timothy M | VP Development Prog ... | Option Exercise | A | 1.16 | 37,500 | 43,388 | 37,500 | |
Dec 07 2011 | IDRA | IDERA PHARMACEUTIC ... | Sullivan Timothy M | VP Development Prog ... | Option Exercise | A | 1.16 | 37,500 | 43,388 | 37,500 | |
Dec 07 2011 | IDRA | IDERA PHARMACEUTIC ... | Arbeit Robert D. | VP Clinical Develop ... | Option Exercise | A | 1.16 | 37,500 | 43,388 | 37,500 | |
Dec 07 2011 | IDRA | IDERA PHARMACEUTIC ... | Arbeit Robert D. | VP Clinical Develop ... | Option Exercise | A | 1.16 | 37,500 | 43,388 | 37,500 | |
Dec 07 2011 | IDRA | IDERA PHARMACEUTIC ... | Arcudi III Louis J | Chief Financial Off ... | Option Exercise | A | 1.16 | 50,000 | 57,850 | 50,000 | |
Dec 07 2011 | IDRA | IDERA PHARMACEUTIC ... | Arcudi III Louis J | Chief Financial Off ... | Option Exercise | A | 1.16 | 50,000 | 57,850 | 50,000 | |
Dec 07 2011 | IDRA | IDERA PHARMACEUTIC ... | AGRAWAL SUDHIR | Chairman, CEO & Pre ... | Option Exercise | A | 1.16 | 125,000 | 144,625 | 125,000 | |
Dec 07 2011 | IDRA | IDERA PHARMACEUTIC ... | AGRAWAL SUDHIR | Chairman, CEO & Pre ... | Option Exercise | A | 1.16 | 125,000 | 144,625 | 125,000 | |
Nov 08 2011 | IDRA | IDERA PHARMACEUTIC ... | ZEIN YOUSSEF EL | Director | Option Exercise | A | 0.00 | 1,124,260 | 0 | 0 | |
Nov 08 2011 | IDRA | IDERA PHARMACEUTIC ... | ZEIN YOUSSEF EL | Director | Option Exercise | A | 1.63 | 2,810,650 | 4,574,333 | 0 | |
Jul 01 2011 | IDRA | IDERA PHARMACEUTIC ... | ZEIN YOUSSEF EL | Director | Grant | A | 2.23 | 5,707 | 12,727 | 586,101 | 580.4 K to 586.1 K (+0.98 %) |
Jun 16 2011 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Option Exercise | A | 2.18 | 20,000 | 43,600 | 20,000 | |
Jun 14 2011 | IDRA | IDERA PHARMACEUTIC ... | WYNGAARDEN JAMES B | Director | Option Exercise | A | 2.18 | 20,000 | 43,600 | 20,000 | |
Jun 14 2011 | IDRA | IDERA PHARMACEUTIC ... | MUELLER HANS | Director | Option Exercise | A | 2.18 | 20,000 | 43,600 | 20,000 | |
Jun 14 2011 | IDRA | IDERA PHARMACEUTIC ... | Slater Eve Elizabeth | Director | Option Exercise | A | 2.18 | 20,000 | 43,600 | 20,000 | |
Jun 14 2011 | IDRA | IDERA PHARMACEUTIC ... | MacCoss Malcolm | Director | Option Exercise | A | 2.18 | 20,000 | 43,600 | 20,000 | |
Jun 14 2011 | IDRA | IDERA PHARMACEUTIC ... | KARR ROBERT W | Director | Option Exercise | A | 2.18 | 20,000 | 43,600 | 20,000 | |
Jun 14 2011 | IDRA | IDERA PHARMACEUTIC ... | ZEIN YOUSSEF EL | Director | Option Exercise | A | 2.18 | 20,000 | 43,600 | 20,000 | |
Jun 14 2011 | IDRA | IDERA PHARMACEUTIC ... | HARTLEY C KEITH | Director | Option Exercise | A | 2.18 | 20,000 | 43,600 | 20,000 | |
Apr 01 2011 | IDRA | IDERA PHARMACEUTIC ... | ZEIN YOUSSEF EL | Director | Grant | A | 2.64 | 4,821 | 12,727 | 580,394 | 575.6 K to 580.4 K (+0.84 %) |
Jan 05 2011 | IDRA | IDERA PHARMACEUTIC ... | ZEIN YOUSSEF EL | Director | Grant | A | 2.89 | 4,404 | 12,728 | 575,573 | 571.2 K to 575.6 K (+0.77 %) |
Dec 28 2010 | IDRA | IDERA PHARMACEUTIC ... | Sullivan Timothy M | VP Development Prog ... | Option Exercise | A | 2.74 | 72,500 | 198,650 | 72,500 | |
Dec 28 2010 | IDRA | IDERA PHARMACEUTIC ... | Arcudi III Louis J | Chief Financial Off ... | Option Exercise | A | 2.74 | 95,000 | 260,300 | 95,000 | |
Dec 28 2010 | IDRA | IDERA PHARMACEUTIC ... | Arbeit Robert D. | VP Clinical Develop ... | Option Exercise | A | 2.74 | 72,500 | 198,650 | 72,500 | |
Dec 28 2010 | IDRA | IDERA PHARMACEUTIC ... | AGRAWAL SUDHIR | Chairman, CEO & Pre ... | Option Exercise | A | 2.74 | 231,000 | 632,940 | 231,000 | |
Dec 03 2010 | IDRA | IDERA PHARMACEUTIC ... | ZEIN YOUSSEF EL | Director | Buy | P | 2.52 | 7,000 | 17,645 | 571,169 | 564.2 K to 571.2 K (+1.24 %) |
Nov 15 2010 | IDRA | IDERA PHARMACEUTIC ... | ZEIN YOUSSEF EL | Director | Buy | P | 2.82 | 25,029 | 70,582 | 564,169 | 539.1 K to 564.2 K (+4.64 %) |
Nov 12 2010 | IDRA | IDERA PHARMACEUTIC ... | Sullivan Timothy M | VP Development Prog ... | Sell | S | 2.72 | 3,837 | 10,437 | 24,914 | 28.8 K to 24.9 K (-13.35 %) |
Nov 10 2010 | IDRA | IDERA PHARMACEUTIC ... | HARTLEY C KEITH | Director | Buy | P | 2.80 | 3,000 | 8,400 | 54,184 | 51.2 K to 54.2 K (+5.86 %) |
Nov 10 2010 | IDRA | IDERA PHARMACEUTIC ... | HARTLEY C KEITH | Director | Buy | P | 2.79 | 7,000 | 19,530 | 51,184 | 44.2 K to 51.2 K (+15.84 %) |
Nov 12 2010 | IDRA | IDERA PHARMACEUTIC ... | ZEIN YOUSSEF EL | Director | Buy | P | 2.75 | 13,000 | 35,750 | 539,140 | 526.1 K to 539.1 K (+2.47 %) |
Nov 10 2010 | IDRA | IDERA PHARMACEUTIC ... | ZEIN YOUSSEF EL | Director | Buy | P | 2.79 | 10,000 | 27,900 | 526,140 | 516.1 K to 526.1 K (+1.94 %) |
Nov 10 2010 | IDRA | IDERA PHARMACEUTIC ... | ZEIN YOUSSEF EL | Director | Buy | P | 2.76 | 19,000 | 52,440 | 516,140 | 497.1 K to 516.1 K (+3.82 %) |
Oct 04 2010 | IDRA | IDERA PHARMACEUTIC ... | MacCoss Malcolm | Director | Grant | A | 3.30 | 1,875 | 6,188 | 1,875 | 0 to 1.9 K |
Jun 18 2010 | IDRA | IDERA PHARMACEUTIC ... | Slater Eve Elizabeth | Director | Option Exercise | A | 4.05 | 16,000 | 64,800 | 16,000 | |
Jun 15 2010 | IDRA | IDERA PHARMACEUTIC ... | WYNGAARDEN JAMES B | Director | Option Exercise | A | 4.16 | 10,000 | 41,600 | 10,000 | |
Jun 15 2010 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Option Exercise | A | 4.16 | 10,000 | 41,600 | 10,000 | |
Jun 15 2010 | IDRA | IDERA PHARMACEUTIC ... | MUELLER HANS | Director | Option Exercise | A | 4.16 | 10,000 | 41,600 | 10,000 | |
Jun 15 2010 | IDRA | IDERA PHARMACEUTIC ... | MacCoss Malcolm | Director | Option Exercise | A | 4.16 | 10,000 | 41,600 | 10,000 | |
Jun 15 2010 | IDRA | IDERA PHARMACEUTIC ... | KARR ROBERT W | Director | Option Exercise | A | 4.16 | 10,000 | 41,600 | 10,000 | |
Jun 15 2010 | IDRA | IDERA PHARMACEUTIC ... | HARTLEY C KEITH | Director | Option Exercise | A | 4.16 | 10,000 | 41,600 | 10,000 | |
Jun 15 2010 | IDRA | IDERA PHARMACEUTIC ... | ZEIN YOUSSEF EL | Director | Option Exercise | A | 4.16 | 10,000 | 41,600 | 10,000 | |
Jun 14 2010 | IDRA | IDERA PHARMACEUTIC ... | ZEIN YOUSSEF EL | Director | Buy | P | 3.61 | 6,000 | 21,660 | 497,140 | 491.1 K to 497.1 K (+1.22 %) |
Jun 11 2010 | IDRA | IDERA PHARMACEUTIC ... | ZEIN YOUSSEF EL | Director | Buy | P | 3.24 | 3,000 | 9,720 | 491,140 | 488.1 K to 491.1 K (+0.61 %) |
Mar 17 2010 | IDRA | IDERA PHARMACEUTIC ... | ZEIN YOUSSEF EL | Director | Gift | G | 0.00 | 23,838 | 0 | 488,140 | 512 K to 488.1 K (-4.66 %) |
Jan 27 2010 | IDRA | IDERA PHARMACEUTIC ... | MacCoss Malcolm | Director | Option Exercise | A | 5.35 | 16,000 | 85,600 | 16,000 | |
Dec 24 2009 | IDRA | IDERA PHARMACEUTIC ... | Sullivan Timothy M | VP Development Prog ... | Option Exercise | A | 5.24 | 70,000 | 366,800 | 70,000 | |
Dec 24 2009 | IDRA | IDERA PHARMACEUTIC ... | Bexon Alice | V.P. Clinical Devel ... | Option Exercise | A | 5.24 | 24,000 | 125,760 | 24,000 | |
Dec 24 2009 | IDRA | IDERA PHARMACEUTIC ... | Arcudi III Louis J | Chief Financial Off ... | Option Exercise | A | 5.24 | 110,000 | 576,400 | 110,000 | |
Dec 24 2009 | IDRA | IDERA PHARMACEUTIC ... | AGRAWAL SUDHIR | CEO, President & CS ... | Option Exercise | A | 5.24 | 300,000 | 1,572,000 | 300,000 | |
Nov 24 2009 | IDRA | IDERA PHARMACEUTIC ... | MUELLER HANS | Director | Buy | P | 5.10 | 4,000 | 20,400 | 10,000 | 6 K to 10 K (+66.67 %) |
Nov 12 2009 | IDRA | IDERA PHARMACEUTIC ... | MUELLER HANS | Director | Buy | P | 5.17 | 2,000 | 10,333 | 6,000 | 4 K to 6 K (+50.00 %) |
Aug 06 2009 | IDRA | IDERA PHARMACEUTIC ... | MUELLER HANS | Director | Buy | P | 6.82 | 1,500 | 10,228 | 4,000 | 2.5 K to 4 K (+60.00 %) |
Jun 16 2009 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Option Exercise | A | 6.72 | 10,000 | 67,200 | 10,000 | |
Jun 25 2009 | IDRA | IDERA PHARMACEUTIC ... | AGRAWAL SUDHIR | CEO, President & CS ... | Payment of Exercise | F | 6.18 | 6,615 | 40,881 | 126,277 | 132.9 K to 126.3 K (-4.98 %) |
Jun 16 2009 | IDRA | IDERA PHARMACEUTIC ... | KARR ROBERT W | Director | Option Exercise | A | 6.72 | 10,000 | 67,200 | 10,000 | |
Jun 16 2009 | IDRA | IDERA PHARMACEUTIC ... | WYNGAARDEN JAMES B | Director | Option Exercise | A | 6.72 | 10,000 | 67,200 | 10,000 | |
Jun 16 2009 | IDRA | IDERA PHARMACEUTIC ... | HARTLEY C KEITH | Director | Option Exercise | A | 6.72 | 10,000 | 67,200 | 10,000 | |
Jun 16 2009 | IDRA | IDERA PHARMACEUTIC ... | Alison Taunton-Rigby | Director | Option Exercise | A | 6.72 | 10,000 | 67,200 | 10,000 | |
Jun 16 2009 | IDRA | IDERA PHARMACEUTIC ... | MUELLER HANS | Director | Option Exercise | A | 6.72 | 10,000 | 67,200 | 10,000 |